Ad5-vector Based Vaccine

adenovirus type 5 vector vaccine for coronavirus variants · CanSino Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad5-vector Based Vaccine, covering 2023-06-18 to 2023-06-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine [Phase 3]

See pricing